Roche exec Pearl Huang rejoins biotech as CEO of Cygnal — Flagship's bet on 'exoneural biology'
Mark Pearl Huang down as the latest illustrious pharma exec to take charge of a biotech.
Jumping from Roche — where she was the SVP and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
